IP Library Granted Patent US 10,696,720
Granted Patent B2
US 10,696,720 · App. 16/546,100 · Granted Jun 30, 2020

Nucleoside triphosphate transporter and uses thereof

Inventors: Floyd E. Romesberg (La Jolla, CA); Yorke Zhang (San Diego, CA)
Assignee: THE SCRIPPS RESEARCH INSTITUTE
C07K14/405C12N9/22C12N15/10C12N15/11C12N15/90C12N2310/20C12N2800/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,696,720
App. No.
16/546,100
Granted
Jun 30, 2020
Kind
B2
Abstract

Disclosed herein are proteins, methods, cells, engineered microorganisms, and kits for generating a modified nucleoside triphosphate transporter from Phaeodactylum tricornutum . Also disclosed herein proteins, methods, cells, engineered microorganisms, and kits for production of a nucleic acid molecule that comprises an unnatural nucleotide utilizing a modified nucleoside triphosphate transporter from Phaeodactylum tricornutum.

Claims (37)

1. A method of increasing production of a nucleic acid molecule in an E. coli cell, comprising:

(a) expressing in the cell a recombinant nucleoside triphosphate transporter, wherein the recombinant nucleoside triphosphate transporter has an amino acid sequence selected from SEQ ID NO: 4, SEQ ID NO: 6 and SEQ ID NO: 8,

(b) incubating the cell with one or more unnatural nucleoside triphosphates, and

(c) transporting the one or more unnatural nucleoside triphosphates into the cell using the recombinant nucleoside triphosphate transporter, wherein the nucleic acid molecule comprises one or more unnatural nucleotides comprising a base selected from the group consisting of

2. The method of claim 1 , wherein the nucleic acid molecule comprises DNA.

3. The method of claim 1 , wherein the nucleic acid molecule comprises RNA.

4. The method of claim 1 , wherein the nucleic acid molecule comprises one or more unnatural nucleotides comprising a base which is

5. The method of claim 1 , wherein the nucleic acid molecule comprises one or more unnatural nucleotides comprising a base which is

6. The method of claim 1 , wherein the one or more unnatural nucleoside triphosphates comprises a base selected from the group consisting of

7. The method of claim 1 , wherein the one or more unnatural nucleoside triphosphates comprises a base which is

8. The method of claim 1 , wherein the one or more unnatural nucleoside triphosphates comprises a base which is

9. A method of increasing production of a DNA nucleic acid molecule in an E. coli cell comprising:

(a) expressing in the cell a recombinant nucleoside triphosphate transporter, wherein the recombinant nucleoside triphosphate transporter has an amino acid sequence comprising selected from SEQ ID NO: 4, SEQ ID NO: 6 and SEQ ID NO: 8,

(b) incubating the cell with one or more unnatural 2′-deoxyribonucleoside triphosphates, and

(c) transporting the one or more unnatural 2′-deoxyribonucleoside triphosphates into the cell using the recombinant nucleoside triphosphate transporter, wherein the one or more unnatural 2′-deoxyribonucleoside triphosphates comprise a base selected from the group consisting of:

10. A method of increasing production of a RNA nucleic acid molecule in an E. coli cell, comprising:

(a) expressing in the cell a recombinant nucleoside triphosphate transporter, wherein the recombinant nucleoside triphosphate transporter has an amino acid sequence selected from SEQ ID NO: 4, SEQ ID NO: 6 and SEQ ID NO: 8,

(b) incubating the cell with one or more unnatural ribonucleoside triphosphates, and

(c) transporting the one or more unnatural ribonucleoside triphosphates into the cell using the recombinant nucleoside triphosphate transporter, wherein the one or more unnatural ribonucleoside triphosphates comprise a base selected from the group consisting of:

11. The method of claim 1 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 4.

12. The method of claim 11 , wherein the one or more unnatural nucleoside triphosphates comprises a base selected from

13. The method of claim 1 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 6.

14. The method of claim 13 , wherein the one or more unnatural nucleoside triphosphates comprises a base selected from

15. The method of claim 1 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 8.

16. The method of claim 15 , wherein the one or more unnatural nucleoside triphosphates comprises a base selected from

17. The method of claim 9 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 4.

18. The method of claim 17 , wherein the one or more unnatural 2′-deoxyribonucleoside triphosphates comprises a base selected from

19. The method of claim 9 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 6.

20. The method of claim 19 , wherein the one or more unnatural 2′-deoxyribonucleoside triphosphates comprises a base selected from

21. The method of claim 9 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 8.

22. The method of claim 21 , wherein the one or more unnatural 2′-deoxyribonucleoside triphosphates comprises a base selected from

23. The method of claim 10 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 4.

24. The method of claim 23 , wherein the one or more unnatural ribonucleoside triphosphates comprises a base selected from

25. The method of claim 10 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 6.

26. The method of claim 25 , wherein the one or more unnatural ribonucleoside triphosphates comprises a base selected from

27. The method of claim 10 , wherein the recombinant nucleoside triphosphate transporter has amino acid sequence SEQ ID NO: 8.

28. The method of claim 27 , wherein the one or more unnatural ribonucleoside triphosphates comprises a base selected from

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2019
From: ROMESBERG, FLOYD E.; ZHANG, YORKE
To: THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 050269/0332 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2019
From: ROMESBERG, FLOYD E.; ZHANG, YORKE
To: THE SCRIPPS RESEARCH INSTITUTE
Reel/Frame 050108/0635 →
Continuity (3)
Continuation 16312901
Provisional Application 62354650 · Jun 24, 2016
Related Publication 20190375803A1 · Dec 12, 2019
Cited By (4)
US 12,281,137 US 12,319,944 US 12,497,642 US 12,655,436